Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 04-2025 | 04-2024 | 04-2023 | 04-2022 | |
| Sales | 59,425 | 56,944 | 50,155 | 53,870 | 49,109 |
| Cost of Goods | 30,900 | 28,389 | 29,401 | 29,532 | 23,632 |
| Gross Profit | 28,525 | 28,555 | 20,754 | 24,338 | 25,477 |
| Operating Expenses | 30,565 | 24,391 | 28,511 | 30,126 | 25,502 |
| Operating Income | -1,140 | 4,553 | -7,356 | -5,256 | 607 |
| Other Income | 211 | 73 | 48 | -11 | -24 |
| Pre-tax Income | -929 | 4,626 | -7,308 | -5,267 | 583 |
| Income Tax | 246 | -75 | -32 | 68 | 35 |
| Net Income Continuous | -1,175 | 4,701 | -7,276 | -5,335 | 548 |
| Net Income | $-1,175 | $4,701 | $-7,276 | $-5,335 | $548 |
| EPS Basic Total Ops | -0.08 | 0.34 | -0.54 | -0.39 | 0.04 |
| EPS Basic Continuous Ops | -0.08 | 0.34 | -0.54 | -0.39 | 0.04 |
| EPS Diluted Total Ops | -0.08 | 0.33 | -0.54 | -0.39 | 0.04 |
| EPS Diluted Continuous Ops | -0.08 | 0.33 | -0.54 | -0.39 | 0.04 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.33 | -0.54 | -0.39 | 0.04 |
| EBITDA(a) | $237 | $6,193 | $-5,489 | $-3,010 | $2,234 |